Follow
ann d thor and ann thor
ann d thor and ann thor
Professor and Chair, University of Colorado
Verified email at cuanschutz.edu
Title
Cited by
Cited by
Year
Revision of the American Joint Committee on Cancer staging system for breast cancer
SE Singletary, C Allred, P Ashley, LW Bassett, D Berry, KI Bland, ...
Journal of clinical oncology 20 (17), 3628-3636, 2002
17862002
Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999
PL Fitzgibbons, DL Page, D Weaver, AD Thor, DC Allred, GM Clark, ...
Archives of pathology & laboratory medicine 124 (7), 966-978, 2000
17852000
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells
Z Zou, A Anisowicz, MJC Hendrix, A Thor, M Neveu, S Sheng, K Rafidi, ...
Science 263 (5146), 526-529, 1994
13111994
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
HB Muss, AD Thor, DA Berry, T Kute, ET Liu, F Koerner, CT Cirrincione, ...
New England Journal of Medicine 330 (18), 1260-1266, 1994
12781994
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers
AD Thor, DH Moore, SM Edgerton, ES Kawasaki, E Reihsaus, HT Lynch, ...
JNCI: Journal of the National Cancer Institute 84 (11), 845-855, 1992
9311992
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
AD Thor, DA Berry, DR Budman, HB Muss, T Kute, IC Henderson, ...
JNCI: Journal of the National Cancer Institute 90 (18), 1346-1360, 1998
7721998
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.
OP Kallioniemi, A Kallioniemi, W Kurisu, A Thor, LC Chen, HS Smith, ...
Proceedings of the National Academy of Sciences 89 (12), 5321-5325, 1992
7501992
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with …
BP Schneider, M Wang, M Radovich, GW Sledge, S Badve, A Thor, ...
Journal of Clinical Oncology 26 (28), 4672, 2008
7182008
HER2 and response to paclitaxel in node-positive breast cancer
DF Hayes, AD Thor, LG Dressler, D Weaver, S Edgerton, D Cowan, ...
New England Journal of Medicine 357 (15), 1496-1506, 2007
7172007
Loss of heterozygosity in normal tissue adjacent to breast carcinomas
G Deng, Y Lu, G Zlotnikov, AD Thor, HS Smith
Science 274 (5295), 2057-2059, 1996
7101996
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
IN Alimova, B Liu, Z Fan, SM Edgerton, T Dillon, SE Lind, AD Thor
Cell cycle 8 (6), 909-915, 2009
6362009
Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72. 3
A Thor, N Ohuchi, CA Szpak, WW Johnston, J Schlom
Cancer research 46 (6), 3118-3124, 1986
5921986
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
B Liu, Z Fan, SM Edgerton, XS Deng, IN Alimova, SE Lind, AD Thor
Cell cycle 8 (13), 2031-2040, 2009
5182009
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
DR Cochrane, S Bernales, BM Jacobsen, DM Cittelly, EN Howe, ...
Breast Cancer Research 16, 1-19, 2014
4352014
Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin-and etoposide-induced apoptosis
XH Yang, TL Sladek, X Liu, BR Butler, CJ Froelich, AD Thor
Cancer research 61 (1), 348-354, 2001
4022001
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual
SE Singletary, C Allred, P Ashley, LW Bassett, D Berry, KI Bland, ...
Surgical Clinics 83 (4), 803-819, 2003
3942003
p53 gene mutations and protein accumulation in human ovarian cancer.
J Kupryjańczyk, AD Thor, R Beauchamp, V Merritt, SM Edgerton, DA Bell, ...
Proceedings of the National Academy of Sciences 90 (11), 4961-4965, 1993
3901993
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma
VL Cryns, A Thor, HJ Xu, SX Hu, ME Wierman, AL Vickery Jr, WF Benedict, ...
New England Journal of Medicine 330 (11), 757-761, 1994
3531994
Expression of ras Oncogene p21 in Prostate Cancer
MV Viola, F Fromowitz, S Oravez, S Deb, G Finkel, J Lundy, P Hand, ...
New England Journal of Medicine 314 (3), 133-137, 1986
3531986
Survival signaling by Notch1: mammalian target of rapamycin (mTOR)–dependent inhibition of p53
SK Mungamuri, XH Yang, AD Thor, K Somasundaram
Cancer research 66 (9), 4715-4724, 2006
3272006
The system can't perform the operation now. Try again later.
Articles 1–20